Zurletrectinib is a tyrosine kinase inhibitor with potential as an antineoplastic agent.
For research use only. We do not sell to patients.
Name | Zurletrectinib |
---|---|
Iupac Chemical Name | (13E,14E,24S,5S)-24,35-difluoro-5-methyl-4-oxa-7,9-diaza-1(5,3)-pyrazolo[1,5-a]pyrimidina-3(3,2)-pyridina-2(1,2)-pyrrolidinacyclononaphan-8-one |
Synonyms | Zurletrectinib; Zvq44E2H6V; ZVQ44E2H6V |
Molecular Formula | C19H19F2N7O2 |
Molecular Weight | 415.40 |
Smile | O=C1NC(C=N2)=C(N2C=C3)N=C3N(C[C@@H](F)C4)C4C5=CC(F)=CN=C5O[C@@H](C)CN1 |
InChiKey | OIBWCYRRWAMTRW-NIUIKUMDSA-N |
InChi | InChI=1S/C19H19F2N7O2/c1-10-6-23-19(29)25-14-8-24-28-3-2-16(26-17(14)28)27-9-12(21)5-15(27)13-4-11(20)7-22-18(13)30-10/h2-4,7-8,10,12,15H,5-6,9H2,1H3,(H2,23,25,29)/t10-,12-,15?/m0/s1 |
CAS Number | 2403703-30-8 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white solid |
---|---|
Purity | 98% Min. |
Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |